Zachary Roberts
Director Técnico/Científico/I+D en ALLOGENE THERAPEUTICS, INC. .
Fortuna: 95 718 $ al 31/05/2024
Cargos activos de Zachary Roberts
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 03/01/2023 | - |
Historial de carrera de Zachary Roberts
Antiguos cargos conocidos de Zachary Roberts.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INSTIL BIO, INC. | Director Técnico/Científico/I+D | 01/03/2020 | 11/11/2022 |
| KITE PHARMA INC | Director Técnico/Científico/I+D | 01/02/2018 | 01/05/2019 |
| AMGEN INC. | Director Técnico/Científico/I+D | 01/01/2015 | 01/07/2015 |
Formación de Zachary Roberts.
| University of Maryland | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Zachary Roberts
- Experiencia
